No Data
No Data
12 Health Care Stocks Moving In Friday's Pre-Market Session
This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Marker Therapeutics Price Target Announced at $8.00/Share by Canaccord Genuity
Marker Therapeutics Initiated at Buy by Canaccord Genuity
Marker Therapeutics Analyst Ratings
Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference